Literature DB >> 6712194

High blood glucose level on hospital admission and poor neurological recovery after cardiac arrest.

W T Longstreth, T S Inui.   

Abstract

To evaluate the relationship between blood glucose and neurological recovery after cardiac arrest, we retrospectively reviewed our experience with 430 consecutive patients resuscitated after out-of-hospital cardiac arrest. All these patients had received variable amounts of intravenous 5% glucose solutions before admission. Awakening patients, those following commands or having comprehensible speech, were classified as to whether they suffered persistent neurological deficits. The mean blood glucose level on hospital admission was higher in 154 patients who never awakened than in 276 who did awaken (mean, 341 versus 262 mg per 100 milliliters; p less than 0.0005). Among the 276 who awakened, 90 patients with persistent neurological deficits had higher mean glucose levels on admission than did 186 without deficits (286 versus 251 mg per 100 milliliters; p less than 0.02). These significant differences persisted after excluding all patients whose glucose levels were higher than 500 mg per 100 milliliters and after controlling for potentially confounding variables using multiple regression analysis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6712194     DOI: 10.1002/ana.410150111

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  17 in total

1.  The effects of intraoperative glucose infusion on portal blood insulin concentration and hepatic mitochondrial redox state during surgery: comparison of short-term and continuous infusions.

Authors:  J Hayakawa; H Motohashi; M Sairenji; O Kobayashi; M Takahashi; Y Usuda
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

Review 2.  General anaesthesia for supratentorial neurosurgery.

Authors:  P Ravussin; O Wilder-Smith
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

3.  The 1998 European Resuscitation Council guidelines for adult advanced life support. Advanced Life Support Working Group of the European Resuscitation Council.

Authors: 
Journal:  BMJ       Date:  1998-06-20

4.  Blood glucose level and outcome after cardiac arrest: insights from a large registry in the hypothermia era.

Authors:  Fabrice Daviaud; Florence Dumas; Nadège Demars; Guillaume Geri; Adrien Bouglé; Tristan Morichau-Beauchant; Yên-Lan Nguyen; Wulfran Bougouin; Frédéric Pène; Julien Charpentier; Alain Cariou
Journal:  Intensive Care Med       Date:  2014-03-25       Impact factor: 17.440

5.  Does early postresuscitation stress hyperglycemia affect 72-hour neurologic outcome? Preliminary observations in the Swine model.

Authors:  James T Niemann; Scott Youngquist; John P Rosborough
Journal:  Prehosp Emerg Care       Date:  2011-04-11       Impact factor: 3.077

6.  The neurologic sequelae of cardiac arrest.

Authors:  W T Longstreth
Journal:  West J Med       Date:  1987-08

7.  The Relationship Between the Decreased Rate of Initial Blood Glucose and Neurologic Outcomes in Survivors of Out-of-Hospital Cardiac Arrest Receiving Therapeutic Hypothermia.

Authors:  Jae-Hyug Woo; Yong Su Lim; Hyuk Jun Yang; Sung Youl Hyun; Jin Seong Cho; Jin Joo Kim; Gun Lee
Journal:  Neurocrit Care       Date:  2017-06       Impact factor: 3.210

Review 8. 

Authors:  J P Nolan; C D Deakin; J Soar; B W Böttiger; G Smith; M Baubin; B Dirks; V Wenzel
Journal:  Notf Rett Med       Date:  2006-02-01       Impact factor: 0.826

9.  Incidence and risk factors for perioperative hyperglycemia in children with traumatic brain injury.

Authors:  Deepak Sharma; Jill Jelacic; Rohini Chennuri; Onuma Chaiwat; Wayne Chandler; Monica S Vavilala
Journal:  Anesth Analg       Date:  2009-01       Impact factor: 5.108

10.  Strict versus moderate glucose control after resuscitation from ventricular fibrillation.

Authors:  Tuomas Oksanen; Markus B Skrifvars; Tero Varpula; Anne Kuitunen; Ville Pettilä; Jouni Nurmi; Maaret Castrén
Journal:  Intensive Care Med       Date:  2007-10-11       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.